Lassa fever primary prevention: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Lassa fever}} | {{Lassa fever}} | ||
{{CMG}} | {{CMG}} | ||
==Primary Prevention== | ==Primary Prevention== | ||
Revision as of 14:24, 6 December 2012
|
Lassa fever Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lassa fever primary prevention On the Web |
|
American Roentgen Ray Society Images of Lassa fever primary prevention |
|
Risk calculators and risk factors for Lassa fever primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Primary Prevention
Control of the Mastomys rodent population is impractical, so measures are limited to keeping rodents out of homes and food supplies, as well as maintaining effective personal hygiene. Gloves, masks, laboratory coats, and goggles are advised while in contact with an infected person.
No vaccine against Lassa fever is currently available, though development is underway. The Mozambique virus closely resembles Lassa fever, while lacking its deadly effects. This virus is being considered for possible use as a vaccine.
Researchers at the USAMRIID facility, where military biologists study infectious diseases, have a promising vaccine candidate. They have developed a replication-competent vaccine against Lassa virus based on recombinant vesicular stomatitis virus vectors expressing the Lassa virus glycoprotein. After a single intramuscular injection, test primates have survived lethal challenge, while showing no clinical symptoms.[1]
References
- ↑ Geisbert TW, Jones S, Fritz EA; et al. (2005). "Development of a new vaccine for the prevention of Lassa fever". PLoS Med. 2 (6): e183. doi:10.1371/journal.pmed.0020183. PMID 15971954.